Dual-detection fluorescent immunochromatographic assay for quantitative detection of SARS-CoV-2 spike RBD-ACE2 blocking neutralizing antibody
- 15 December 2021
- journal article
- research article
- Published by Elsevier in Biosensors and Bioelectronics
- Vol. 199, 113883
Abstract
No abstract availableKeywords
Funding Information
- China National Nuclear Corporation
This publication has 28 references indexed in Scilit:
- SARS-CoV-2 Assays To Detect Functional Antibody Responses That Block ACE2 Recognition in Vaccinated Animals and Infected PatientsJournal of Clinical Microbiology, 2020
- A SARS-CoV-2 surrogate virus neutralization test based on antibody-mediated blockage of ACE2–spike protein–protein interactionNature Biotechnology, 2020
- The receptor-binding domain of the viral spike protein is an immunodominant and highly specific target of antibodies in SARS-CoV-2 patientsScience Immunology, 2020
- A human neutralizing antibody targets the receptor-binding site of SARS-CoV-2Nature, 2020
- Rapid and Sensitive Detection of anti-SARS-CoV-2 IgG, Using Lanthanide-Doped Nanoparticles-Based Lateral Flow ImmunoassayAnalytical Chemistry, 2020
- SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease InhibitorCell, 2020
- Characterization of spike glycoprotein of SARS-CoV-2 on virus entry and its immune cross-reactivity with SARS-CoVNature Communications, 2020
- Synthetic ratiometric fluorescent probes for detection of ionsChemical Society Reviews, 2019
- A digital microfluidic system for serological immunoassays in remote settingsScience Translational Medicine, 2018
- Guidelines for immunoassay data processing.Clinical Chemistry, 1985